EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:

6 Months Ended

Sep. 30, 2012

EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:

EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:

2.             EARNINGS PER SHARE AND STOCKHOLDERS’ EQUITY:

Earnings Per Share

A reconciliation of the numerator and denominator of basic and diluted earnings per share is shown below (in thousands, except per share amounts):

	For the quarter ended September 30					For the six months ended September 30
	2012			2011		2012			2011
Basic earnings per share:
Net earnings from continuing operations	$	16,372		$	11,839	$	29,571		$	20,939
Net earnings from discontinued operations	—			1,138		—			2,053
Net earnings	$	16,372		$	12,977	$	29,571		$	22,992
Net earnings (loss) attributable to noncontrolling interest	(139		)	685		(273		)	(275		)
Net earnings attributable to Acxiom	$	16,511		$	12,292	$	29,844		$	23,267
Basic weighted-average shares outstanding	75,009			80,985		75,741			80,963
Basic earnings per share:
Continuing operations	$	0.22		$	0.15	$	0.39		$	0.26
Discontinued operations	—			0.01		—			0.03
Net earnings	$	0.22		$	0.16	$	0.39		$	0.28
Net earnings attributable to noncontrolling interest	—			0.01		—			—
Net earnings attributable to Acxiom	$	0.22		$	0.15	$	0.39		$	0.29
Diluted earnings per share:
Basic weighted-average shares outstanding	75,009			80,985		75,741			80,963
Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method	2,016			612		1,800			842
Diluted weighted-average shares outstanding	77,025			81,597		77,541			81,805
Diluted earnings per share:
Continuing operations	$	0.21		$	0.15	$	0.38		$	0.26
Discontinued operations	—			0.01		—			0.03
Net earnings	$	0.21		$	0.16	$	0.38		$	0.28
Net earnings attributable to noncontrolling interest	—			0.01		—			—
Net earnings attributable to Acxiom	$	0.21		$	0.15	$	0.38		$	0.28

Some earnings per share amounts may not add due to rounding.

As of September 30, 2012, the Company had options and warrants outstanding providing for the purchase of approximately 9.8 million shares of common stock together with restricted stock units relating to 1.2 million shares of stock.  Options, warrants and restricted stock units that were outstanding during the periods presented, but were not included in the computation of diluted earnings per share because the effect was antidilutive are shown below (in thousands, except per share amounts):

	For the quarter ended September 30		For the six months ended September 30
	2012	2011	2012	2011
Number of shares outstanding under options, warrants and restricted stock units	4,762	10,582	7,093	10,069
Range of exercise prices for options and warrants	$17.76-$62.06	$11.50-$62.06	$15.31-$62.06	$13.14-$62.06

Stockholders’ Equity

On August 29, 2011, the board of directors adopted a common stock repurchase program.  That program was subsequently modified and expanded on December 5, 2011, and again on May 24, 2012.  Under the modified common stock repurchase program, the Company may purchase up to $150.0 million worth of its common stock through the period ending May 24, 2013.  During the six months ended September 30, 2012, the Company repurchased 3.2 million shares of its common stock for $47.2 million.  Cash paid for acquisition of treasury stock in the condensed consolidated statement of cash flows may differ from the aggregate purchase price due to trades made during one fiscal period that settle in a different fiscal period.  Through September 30, 2012, the Company had repurchased 9.0 million shares of its stock for $115.4 million, leaving remaining capacity of $34.6 million under the stock repurchase program.